{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:17:48Z","timestamp":1785543468296,"version":"3.56.0"},"reference-count":128,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000902","name":"Pediatric Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000902","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008258","name":"Hyundai Hope On Wheels","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non\u2010Hodgkin lymphoma (NHL) is a heterogeneous group of lymphoid malignancies with high incidence in adolescents and young adults (AYAs). The most common diseases include diffuse large B\u2010cell lymphoma, anaplastic large cell lymphoma, Burkitt lymphoma, lymphoblastic lymphoma, and primary mediastinal large B\u2010cell lymphoma. In comparison to younger children and adults, AYAs (15\u201339 years) with NHL present a specific set of challenges including variations in tumor biology, inconsistent treatment, pharmacodynamics, and psychosocial barriers. While survival of AYAs with NHL has improved, cure rates remain suboptimal. Incorporation of novel agents into pediatric\u2010inspired treatment regimens specifically designed for NHL in AYAs has led to improved outcomes. Consideration of AYAs as a distinct population in the diagnosis and treatment of NHL is encouraged.<\/jats:p>","DOI":"10.1002\/pbc.27073","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T11:55:29Z","timestamp":1525866929000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["NHL in adolescents and young adults: A unique population"],"prefix":"10.1002","volume":"65","author":[{"given":"Jessica","family":"Hochberg","sequence":"first","affiliation":[{"name":"Department of Pediatrics New York Medical College  Valhalla New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Flower","sequence":"additional","affiliation":[{"name":"Department of Pediatrics New York Medical College  Valhalla New York"},{"name":"Department of Microbiology &amp; Immunology New York Medical College  Valhalla New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Brugieres","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Institut Gustave Roussy  Villejuif France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2075-434X","authenticated-orcid":false,"given":"Mitchell S.","family":"Cairo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics New York Medical College  Valhalla New York"},{"name":"Department of Microbiology &amp; Immunology New York Medical College  Valhalla New York"},{"name":"Department of Medicine New York Medical College  Valhalla New York"},{"name":"Department of Pathology New York Medical College  Valhalla New York"},{"name":"Department of Cell Biology &amp; Anatomy New York Medical College  Valhalla New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"e_1_2_10_2_1","volume-title":"Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival, 1975\u20132000","author":"Bleyer A","year":"2006"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14035"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-33679-4_4"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07393.x"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.06988.x"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.09024.x"},{"key":"e_1_2_10_8_1","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non\u2010Hodgkin's lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy SB","year":"1980","journal-title":"Semin Oncol"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7203"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.0745"},{"key":"e_1_2_10_11_1","volume-title":"World Health Organization Classification of Tumors","author":"Jaffe ES","year":"2000"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21619"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-077982"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012914"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0102-68"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181bb9a18"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4213"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.312"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-349662"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-136465"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055759"},{"key":"e_1_2_10_23_1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe ES","year":"2008"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3947"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.4342"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.0985"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.3369"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05735.x"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04134.x"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3370"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-563627"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.255"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13040"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70664-7"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60313-X"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70235-2"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61040-4"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70481-3"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-422709"},{"key":"e_1_2_10_42_1","first-page":"113","article-title":"Advances in the diagnosis and treatment of childhood and adolescent B\u2010cell non\u2010Hodgkin lymphoma","volume":"13","author":"El\u2010Mallawany NK","year":"2015","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1841"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-575092"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.030809"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214561"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2062"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13764"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.9585"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.2345"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571091"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1487"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.205"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24591"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.5411"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25187"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14740"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270785"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2016.11.001"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403888"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-526202"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134270"},{"key":"e_1_2_10_64_1","first-page":"45","article-title":"Risk\u2010adapted therapy for patients with relapsed or refractory ALCL\u2014final report of the prospective ALCL\u2010relapse trial of the EICNHL","volume":"171","author":"Ruf S","year":"2015","journal-title":"Br J Haematol"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0402"},{"key":"e_1_2_10_66_1","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1182\/blood.V124.21.3095.3095","article-title":"Four\u2010year survival data from an ongoing pivotal phase 2 study of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma","volume":"124","author":"Pro B","year":"2014","journal-title":"Blood"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70095-0"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt378"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-617779"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1511045"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0810958105"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.7326\/L16-0037"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2764-1"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401310"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11615"},{"key":"e_1_2_10_76_1","first-page":"416","article-title":"Intensive ALL\u2010type therapy without local radiotherapy provides a 90% event\u2010free survival for children with T\u2010cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter A","year":"2000","journal-title":"Blood"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.6.1368"},{"key":"e_1_2_10_78_1","volume-title":"Cancer Medicine","author":"Cairo MS","year":"2003"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605093341906"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s100249910052"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12042"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70314-0"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10725"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12882"},{"key":"e_1_2_10_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20550"},{"key":"e_1_2_10_86_1","first-page":"34","article-title":"NOTCH1\/FBXW7 mutational status differs qualitatively and quantitatively in T\u2010Lineage lymphoblastic lymphoma (T\u2010LL) and leukemi (T\u2010ALL)","volume":"3","author":"Baelydier","year":"2009","journal-title":"Hematol Meet Rep"},{"key":"e_1_2_10_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-474148"},{"key":"e_1_2_10_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.6.1024"},{"key":"e_1_2_10_89_1","first-page":"1464","article-title":"Improved event\u2010free survival (EFS) with high dose methotrexate (HDM) in T\u2010cell lymphoblastic leukemia (T\u2010ALL) and advanced lymphoblastic lymphoma (T\u2010NHL): a Pediatric Oncology Group (POG) study","volume":"20","author":"Asselin B","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004263221701"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.2707"},{"key":"e_1_2_10_92_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0973"},{"key":"e_1_2_10_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70200-8"},{"key":"e_1_2_10_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0110"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197601)37:1<123::AID-CNCR2820370119>3.0.CO;2-7"},{"key":"e_1_2_10_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198303103081003"},{"key":"e_1_2_10_97_1","first-page":"2295","article-title":"Outcome of Children's Cancer Group (CCG) 5941: a pilot study for the treatment of newly diagnosed pediatric patients with disseminated lymphoblastic lymphoma","volume":"19","author":"Abromowitch M","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb06423.x"},{"key":"e_1_2_10_99_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.1.26"},{"key":"e_1_2_10_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.7.1935"},{"key":"e_1_2_10_101_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.359"},{"key":"e_1_2_10_102_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.9.537"},{"key":"e_1_2_10_103_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.11.1628"},{"key":"e_1_2_10_104_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409049726"},{"key":"e_1_2_10_105_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.7.1078"},{"key":"e_1_2_10_106_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609054867"},{"key":"e_1_2_10_107_1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.V124.21.370.370","article-title":"Favorable outcome in a large cohort of prospectively treated adult patients with T\u2010lymphoblastic lymphoma (T\u2010LBL) despite slowly evolving complete remission assessed by conventional radiography","volume":"124","author":"Gokbuget N","year":"2014","journal-title":"Blood"},{"key":"e_1_2_10_108_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.5385"},{"key":"e_1_2_10_109_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008202808144"},{"key":"e_1_2_10_110_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.11.2927"},{"key":"e_1_2_10_111_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1483"},{"key":"e_1_2_10_112_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.3367"},{"key":"e_1_2_10_113_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.426"},{"key":"e_1_2_10_114_1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V124.21.795.795","article-title":"Nelarabine in combination with etoposide and cyclophosphamide is active in first relapse of childhood T\u2010acute lymphocytic leukemia (T\u2010ALL) and T\u2010lymphoblastic lymphoma (T\u2010LL)","volume":"124","author":"Whitlock J","year":"2014","journal-title":"Blood"},{"key":"e_1_2_10_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.06.003"},{"key":"e_1_2_10_116_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-418640"},{"key":"e_1_2_10_117_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-199679"},{"key":"e_1_2_10_118_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.1142"},{"key":"e_1_2_10_119_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.185"},{"key":"e_1_2_10_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860901)58:5<1179::AID-CNCR2820580534>3.0.CO;2-E"},{"key":"e_1_2_10_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21461"},{"key":"e_1_2_10_122_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23060"},{"key":"e_1_2_10_123_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e328320d54c"},{"key":"e_1_2_10_124_1","doi-asserted-by":"publisher","DOI":"10.1021\/js980173a"},{"key":"e_1_2_10_125_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200039030-00004"},{"key":"e_1_2_10_126_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.3473"},{"key":"e_1_2_10_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(05)70463-6"},{"key":"e_1_2_10_128_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060414"},{"key":"e_1_2_10_129_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746020-00003"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.27073","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.27073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T07:09:04Z","timestamp":1695452944000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.27073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":128,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1002\/pbc.27073"],"URL":"https:\/\/doi.org\/10.1002\/pbc.27073","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"2017-07-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e27073"}}